Natixis
- SEC CIK
- 0001274981
- Latest filing
- Aug 13, 2026
TNDM holding history
Tandem Diabetes Care Inc in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TNDM overviewAll 13F holders of TNDMFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −5,500−100.0% | Sold out | Holders |
| Q1 2026 | 5,500 | $105.4K | <0.1% | +5,500 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −12,200−100.0% | Sold out | Holders |
| Q2 2025 | 12,200 | $227.4K | <0.1% | +12,200 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −12,200−100.0% | Sold out | Holders |
| Q3 2024 | 12,200 | $517.4K | <0.1% | +12,200 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −18,151−100.0% | Sold out | Holders |
| Q1 2023 | 18,151 | $737.1K | <0.1% | −542−2.9% | Reduced | Holders |
| Q4 2022 | 18,693 | $840.3K | <0.1% | −672−3.5% | Reduced | Holders |
| Q3 2022 | 19,365 | $968.0K | <0.1% | −854−4.2% | Reduced | Holders |
| Q2 2022 | 20,219 | $1.20M | <0.1% | +20,219 | New | Holders |